ArticleThe journal of allergy and clinical immunology. Global2026
A novel ambient air sampler for detection of allergens and endotoxin.
Article in The journal of allergy and clinical immunology. Global, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Current methods for measuring airborne allergen and endotoxin exposure in indoor environments rely on air sampling (using flow rates traditionally lower than 10 L/min) or using settled dust as a proxy, both of which have limitations. Objectives: We sought to develop a novel, user-friendly ambient air sampling device (ambient air sampler [AAS]) for accurate and efficient measurement of allergens and endotoxin. Methods: The AAS is a small, quiet, lightweight device that draws air at a high flow rate (>500 L/min) across a filter to collect airborne particles. AAS devices sampled homes across South Wales, UK, and Central Virginia, USA. Devices were run alongside Institute of Occupational Medicine samplers, with both operating for 10 hours. Devices were also operated for 7 days alongside electrostatic dust collectors, which passively sampled the environment for the equivalent time. Following extraction, indoor and food allergens were quantified by multiplex assays and ELISA. Endotoxin was measured using Recombinant Factor C assay. Results: After 10 hours, the AAS collected 13 allergens from dust mite, cat, dog, mouse, and multiple foods, with positivity rates up to 100%. In comparison, Institute of Occupational Medicine samplers collected 5 allergens in total, with much lower positivity rates. After 7 days, the AAS collected 10 different indoor allergens and 13 different food allergens across UK and US homes. Allergens from cat, dog, milk, egg, and peanut were collected in almost every home. The AAS collected all allergens more frequently and in significantly higher amounts than the electrostatic dust collectors. The AAS also collected airborne endotoxin in every home sampled, from as little as 1-day sampling time. Conclusions: The AAS developed herein provides a standardizable method for monitoring airborne allergen and endotoxin exposure, with potential applicability to other biological environmental agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.